子宫颈癌ⅢC1期患者术后生存列线图构建及其临床应用价值分析

陈秀杰, 何玉, 胡晓文, 吴盼盼, 朱曼曼

中国实用妇科与产科杂志 ›› 2025, Vol. 41 ›› Issue (7) : 742-746.

PDF(1378 KB)
PDF(1378 KB)
中国实用妇科与产科杂志 ›› 2025, Vol. 41 ›› Issue (7) : 742-746. DOI: 10.19538/j.fk2025070116
论著

子宫颈癌ⅢC1期患者术后生存列线图构建及其临床应用价值分析

作者信息 +

Construction of postoperative survival nomogram in patients with stage ⅢC1 cervical cancer and analysis of its clinical application value

Author information +
文章历史 +

摘要

目的 探讨子宫颈癌ⅢC1期患者的预后影响因素,建立列线图以探讨其在预后评估中的价值。方法 以2016年1月至2020年12月于蚌埠医科大学第一附属医院行子宫颈癌根治术并经术后病理诊断为子宫颈癌ⅢC1期的95例患者为研究对象,通过COX风险回归分析筛选子宫颈癌ⅢC1期患者的预后影响因素,并建立列线图,采用校准曲线、受试者工作特征(ROC)曲线和决策曲线分析(DCA)对其进行评价。结果 肿瘤直径≥4cm、宫旁受累、淋巴结比率(LNR)≥0.22是子宫颈癌ⅢC1期患者3年总生存率(OS)的危险因素;肿瘤直径≥4cm、淋巴脉管间隙浸润、LNR≥0.22是子宫颈癌ⅢC1期患者3年无病生存率(DFS)的危险因素。列线图的校准曲线显示该模型预测准确度高,ROC曲线表明模型具有良好的准确率,DCA曲线显示该模型具有较好的临床应用价值。结论 肿瘤直径、LNR、宫旁受累、淋巴脉管间隙浸润是影响子宫颈癌ⅢC1期患者预后的危险因素。所构建的列线图可能有利于指导医生对其进行分层管理,采取综合治疗以期改善预后。

Abstract

Objective To analyze factors affecting the prognosis of patients with stage ⅢC1 cervical cancer and to develop a nomogram for exploring its value in prognosis evaluation. Methods A total of 91 patients with pathological diagnosis of stage ⅢC1 cervical cancer were included as research subjects, who underwent radical hysterectomy at the First Affiliated Hospital of Bengbu Medical University between January 2016 and December 2020. Prognostic factors were identified using Cox proportional hazards regression analysis, and a nomogram was constructed. The nomogram was evaluated using calibration curves, receiver operating characteristic (ROC) curves, and decision curve analysis (DCA). Results Tumor diameter ≥4cm, paracervical involvement, and lymph node ratio (LNR) ≥0.22 were the risk factors for 3-year OS of the patients with stage ⅢC1 cervical cancer. Tumor diameter ≥4cm, lymphovascular space invasion (LVSI), and LNR ≥0.22 were the risk factors for 3-year DFS of the patients with stage ⅢC1 cervical cancer. The calibration curves of nomogram demonstrated high prediction accuracy of this model, the ROC curves showed high predictive accuracy of the model, and DCA curve confirmed the clinical utility of the model. Conclusions Tumor size, LNR, paracervical involvement, and LVSI are risk factors affecting the prognosis of the patients with stage ⅢC1 cervical cancer. The constructed nomogram may help to guide doctors in stratification management and to take comprehensive treatment in order to improve patient outcomes.

关键词

子宫颈癌ⅢC1期 / 预测模型 / 列线图 / 预后

Key words

stage ⅢC1 cervical cancer / prediction model / nomogram / prognosis

引用本文

导出引用
陈秀杰, 何玉, 胡晓文, . 子宫颈癌ⅢC1期患者术后生存列线图构建及其临床应用价值分析[J]. 中国实用妇科与产科杂志. 2025, 41(7): 742-746 https://doi.org/10.19538/j.fk2025070116
CHEN Xiu-jie, HE Yu, HU Xiao-wen, et al. Construction of postoperative survival nomogram in patients with stage ⅢC1 cervical cancer and analysis of its clinical application value[J]. Chinese Journal of Practical Gynecology and Obstetrics. 2025, 41(7): 742-746 https://doi.org/10.19538/j.fk2025070116
中图分类号: R711.74   

参考文献

[1]
姚一菲, 孙可欣, 郑荣寿. 《2022全球癌症统计报告》解读:中国与全球对比[J]. 中国普外基础与临床杂志, 2024, 31(7):769-780. DOI:10.7507/1007-9424.202406046.
[2]
中国抗癌协会肿瘤内分泌专业委员会. 子宫颈癌手术分期中国专家共识(2023年版)[J]. 中国实用妇科与产科杂志, 2023, 39(10):996-1002. DOI: 10.19538/j.fk2023100109.
[3]
周晖, 刘昀昀, 罗铭, 等. 《2024 NCCN子宫颈癌临床实践指南(第1版)》更新解读[J]. 中国实用妇科与产科杂志, 2023, 39(11):1119-1121. DOI 10.19538/j.fk2023020115.
[4]
Zhang W, Chen C, Liu P, et al. Impact of pelvic MRI in routine clinical practice on staging of ⅠB1-ⅡA2 cervical cancer[J]. Cancer Manag Res, 2019, 11:3603-3609. DOI:10.2147/CMAR.S197496.
[5]
Li Z, Duan H, Guo J, et al. Discussion on the rationality of FIGO 2018 stage ⅢC for cervical cancer with oncological outcomes:a cohort study[J]. Ann Transl Med, 2022, 10(2):122. DOI:10.21037/atm-21-6374.
[6]
李艳, 袁婷婷, 周苏芹, 等. 紫癜性肾炎患儿肾小球滤过率下降风险预测及列线图的建立[J]. 中国实用儿科杂志, 2025, 40(5):407-412.DOI:10.19538/j.ek2025050612.
[7]
罗玉婷, 陈纯玲, 郭予雄, 等. 先天性心脏病术后脓毒症患儿列线图预后模型的构建与验证[J]. 中国实用儿科杂志, 2024, 39(2):119-124.DOI:10.19538/j.ek2024020609.
[8]
Wang J, Zhanghuang C, Tan X, et al. A nomogram for predicting cancer-specific survival of osteosarcoma and ewing's sarcoma in children:a seer database analysis[J]. Front Public Health, 2022, 10:837506. DOI:10.3389/fpubh.2022.837506.
Osteosarcoma (OSC) and Ewing's sarcoma (EWS) are children's most common primary bone tumors. The purpose of the study is to develop and validate a new nomogram to predict the cancer-specific survival (CSS) of childhood OSC and EWS.
[9]
He Y, Luo L, Shan R, et al. Development and validation of a nomogram for predicting postoperative early relapse and survival in hepatocellular carcinoma[J]. J Natl Compr Canc Netw, 2023, 22(1D):e237069. DOI:10.6004/jnccn.2023.7069.
[10]
Wright JD, Matsuo K, Huang Y, et al. Prognostic performance of the 2018 international federation of gynecology and obstetrics cervical cancer staging guidelines[J]. Obstet Gynecol, 2019, 134(1):49-57. DOI:10.1097/AOG.0000000000003311.
To examine the prognostic performance of the revised 2018 International Federation of Gynecology and Obstetrics (FIGO) cervical cancer staging schema.We used the National Cancer Database to identify women with cervical cancer diagnosed from 2004 to 2015. Using clinical and pathologic data, each patient's stage was classified using three staging schemas: American Joint Committee on Cancer 7th edition, FIGO 2009 and FIGO 2018. The FIGO 2018 revised staging classifies stage IB tumors into three substages based on tumor size (IB1-IB3) and classifies patients with positive lymph nodes (pathologically or clinically detected) as stage IIIC1 (positive pelvic nodes) or IIIC2 (positive para-aortic nodes). Five-year survival rates were estimated for each stage grouping. We sought to determine whether the 2018 FIGO staging system was able to offer improved 5-year survival rate differentiation compared with older staging schemas.A total of 62,212 women were identified. The classification of stage IB tumors into three substages improved discriminatory ability. Five-year survival in the FIGO 2018 schema was 91.6% (95% CI 90.4-92.6%) for stage IB1 tumors, 83.3% (95% CI 81.8-84.8%) for stage IB2 neoplasms, and 76.1% (95% CI 74.3-77.8%) for IB3 lesions. In contrast, for women with stage III tumors, higher FIGO staging was not consistently associated with worse 5-year survival rates: stage IIIA (40.7%, 95 CI 37.1-44.3%), stage IIIB (41.4%; 95% CI 39.9-42.9%), stage IIIC1 (positive pelvic nodes) was 60.8% (95% CI 58.7-62.8%) and stage IIIC2 37.5% (95% CI 33.3-41.7%).The FIGO 2018 staging schema provides improved discriminatory ability for women with stage IB tumors; however, classification of all women with positive lymph nodes into a single stage results in a very heterogeneous group of patients with highly variable survival rates.
[11]
Duan H, Li H, Kang S, et al. Rationality of FIGO 2018 ⅢC restaging of cervical cancer according to local tumor size:A cohort study[J]. Acta Obstet Gynecol Scand, 2023, 102(8):1045-1052. DOI:10.1111/aogs.14612.
FIGO 2018 IIIC remains controversial for the heterogeneity of its prognoses. To ensure a better management of cervical cancer patients in Stage IIIC, a revision of the FIGO IIIC version classification is required according to local tumor size.
[12]
Wang M, Ma M, Yang L, et al. Development and validation of a nomogram for predicting pelvic lymph node metastasis and prognosis in patients with cervical cancer[J]. Front Oncol, 2022, 12:952347. DOI:10.3389/fonc.2022.952347.
Cervical cancer (CC) is one of the main causes of death among gynecological malignancies. Patients with CC with lymph node metastasis (LNM) have poor prognoses. We investigated the risk factors and prognosis of LNM in patients with CC patients using data from the SEER database.
[13]
李梦琦, 王璐, 郭依琳, 等. 3种炎症指标与早期子宫颈癌盆腔淋巴结转移的相关性研究[J]. 中国实用妇科与产科杂志, 2023, 39(4):466-469. DOI:10.19538/j.fk2023040117.
[14]
胡鹏, 王宏兵. 淋巴结转移对中晚期子宫颈癌患者预后影响研究[J]. 中国实用妇科与产科杂志, 2022, 38(7):748-751.DOI:10.19538/j.fk2022070117.
[15]
陈林, 程安然, 陈锐, 等. 淋巴结比率可作为早期宫颈癌生存和复发的预测因子[J]. 中山大学学报(医学科学版), 2021, 42(6):950-954. DOI: 10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).2021.0619.
[16]
王倩, 张敏, 冯晓宇. 非小细胞肺癌与脉管癌栓的相关性及对手术后预后的影响[J]. 实用癌症杂志, 2023, 38(1):148-151. DOI:10.3969/j.issn.1001-5930.2023.01.043.
[17]
刘萍, 黎志强, 柳攀, 等. FIGO 2018子宫颈癌分期Ⅲ期各亚期设置合理性探讨[J]. 中国实用妇科与产科杂志, 2021, 37(6):669-672. DOI:10.19538/j.fk2021060116.
[18]
Balaya V, Guani B, Magaud L, et al. Validation of the 2018 FIGO classification for cervical cancer:lymphovascular space invasion should be considered in ⅠB1 Stage[J]. Cancers (Basel), 2020, 12(12):3554.DOI:10.3390/cancers12123554.
[19]
Chang H, Wang M, Liu Y, et al. Parametrial involvement and decreased survival of women with FIGO stage ⅢC1 cervical cancer[J]. J Gynecol Oncol, 2023, 34(4):e46. DOI:10.3802/jgo.2023.34.e46.
To evaluate the effect of parametrial status on FIGO stage IIIC1 cervical cancer.A retrospective study was conducted from June 1, 2009, to December 31, 2018.Patients with stage IIIC1 cervical cancer were included and stratified into two groups based on the status of parametrial involvement. Patients with IIIA or IIIB were selected as control. The primary outcomes are overall survival (OS) and progression-free survival (PFS).Of 586 patients included, 377 patients were stage IIIC1 (group A) and 209 patients were stage IIIA/IIIB (group B). Compared control, stage IIIC1 was not associated with worse 5-year OS or PFS. Of the stage IIIC1 patients, 58.1% without parametrial involvement (group A1) and 41.9% with parametrial involvement (group A2). Patients of group A1 showed a better prognosis than group A2 both in 5-year rates of OS (79.09% vs. 59.43%, p<0.001) and PFS (73.27% vs. 56.95%, p=0.0002). However, patients of group A1 showed a better prognosis than group B both in OS and PFS. Also, patients of group A2 showed a comparable prognosis to group B both in OS and PFS.Reclassification of stage IIIC1 cervical cancer without parametrial into a new stage is more appropriate and improves discriminatory ability.© 2023. Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology, and Japan Society of Gynecologic Oncology.

基金

安徽高校自然科学研究项目(2023byzd057)

PDF(1378 KB)

Accesses

Citation

Detail

段落导航
相关文章

/